Search
Lineage Cell Therapeutics Inc
LCTXAdd to Watchlist
1.080USD
-0.020-1.80%
Close 07-31 16:00（ET）Quotes delayed by 15 min
269.24MMarket Cap
LossP/E TTM
Lineage Cell Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Lineage Cell Therapeutics Inc is 6.55, ranking 284 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.89, which is -4.63% below the recent high of -3.71 and -267.44% above the recent low of -14.30.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.